Related Experiment Video
Updated: Aug 9, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas
Yao-Chi Liu1, Chen-Yang Shen, Hurng-Sheng Wu
1Division of General Surgery, Tri-Service General Hospital, No. 325, Sec 2, Cheng-Kung Road, Taipei, Taiwan, China. dlyaochi@yahoo.com.tw
Aim:
To study the role of CDH1/E-cadherin (E-cad) gene alteration profiles including mutation, loss of heterozygosity (LOH), promoter polymorphism and hypermethylation in mechanisms of CDH1 inactivation in gastric carcinoma (GC).
Methods:
Specimens were collected surgically from 70 patients with GC. Allelotyping PCR and detection of LOH, denaturing high pressure liquid chromatography and DNA sequencing, restriction fragment length polymorphism analysis, methylation specific PCR, and immunohistochemical staining were used.
Results:
Promoter polymorphism was not a major mechanism of E-cad inactivation. Only one truncating mutation was found in a diffuse type tumor (3%). Both LOH and promoter hypermethylation were major mechanisms of E-cad inactivation, but interestingly, there was a negative association between the fraction of allelic loss (LOH) in tumors and hypermethylation of CDH1. Therefore LOH and hypermethylation were two different tumorigenic pathways involved in GC.
Conclusion:
Given the findings that somatic mutation was extremely low and the relationship between LOH and hypermethylation was inverse, any two combinations of these three factors cannot fulfill the classical two-hit hypothesis of CDH1 inactivation. Thus, other mechanisms operating at the transcriptional level or at the post-translational level might be required to induce E-cadherin inactivation.
Insights
CDH1 gene inactivation in gastric cancer involves loss of heterozygosity (LOH) and promoter hypermethylation, but not typically mutations or polymorphisms. These two major mechanisms appear to be independent pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- CDH1/E-cadherin (E-cad) is a crucial tumor suppressor gene.
- Alterations in CDH1 are implicated in gastric carcinoma (GC) pathogenesis.
- Understanding E-cad inactivation mechanisms is vital for GC research.
Purpose of the Study:
- To investigate CDH1 gene alteration profiles in gastric carcinoma.
- To determine the roles of mutation, LOH, promoter polymorphism, and hypermethylation in CDH1 inactivation.
- To elucidate the pathways leading to E-cad loss in GC.
Main Methods:
- Analysis of 70 surgically collected GC specimens.
- Utilized techniques including PCR, LOH detection, DNA sequencing, RFLP, methylation-specific PCR, and immunohistochemistry.
- Examined mutation, LOH, promoter polymorphism, and hypermethylation of CDH1.
Main Results:
- Promoter polymorphism and somatic mutations were infrequent mechanisms of E-cad inactivation in GC.
- Loss of heterozygosity (LOH) and CDH1 promoter hypermethylation were identified as major inactivation mechanisms.
- An inverse relationship was observed between LOH and hypermethylation, suggesting distinct tumorigenic pathways.
Conclusions:
- The classical two-hit hypothesis for CDH1 inactivation is not met by common combinations of mutation, LOH, and hypermethylation.
- E-cadherin inactivation in GC likely involves additional mechanisms.
- Further research into transcriptional or post-translational regulation of E-cadherin is warranted.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Abnormal Proliferation
Structure of Cadherins
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
